← Back to Search

Behavioral Intervention

Written Exposure Therapy -for Suicide for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Research Sponsored by Boston VA Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-month, 4-month follow-up
Awards & highlights

Study Summary

This trial will compare the Wet-S+ treatment to the usual treatment for high-risk, suicidal service members with PTSD or posttraumatic stress. The primary outcome is suicide risk and PTS symptom severity.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-month, 4-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-month, 4-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Clinician Administered PTSD Scale Scores
Change in Self-Injurious Thoughts and Behaviors Interview Scores
Change in medical record outcomes
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Written Exposure Therapy -for SuicideExperimental Treatment1 Intervention
Written Exposure Therapy-for Suicide (WET-S) consists of 5 treatment sessions. Each session includes a written exposure exercise. It also includes CRP. Participants assigned to WET-S will complete the CRP prior to beginning their writing in session 1. Patient use of the CRP since the previous session will be briefly reviewed at the start of each WET-S session to manage safety and problem solve fluctuations in risk during treatment.
Group II: Treatment as UsualActive Control1 Intervention
The TAU condition consists of daily contact and patient centered care by the acute psychiatric inpatient unit provider team. TAU includes initial stabilization, nurse case management, medication management, psychoeducation groups, and discharge planning. Patients engage with the provider team daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Written Exposure Therapy -for Suicide
2020
N/A
~100

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioOTHER
452 Previous Clinical Trials
91,319 Total Patients Enrolled
Boston VA Research Institute, Inc.Lead Sponsor
22 Previous Clinical Trials
10,711 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment currently welcoming new participants?

"As indicated on clinicaltrials.gov, this experimental trial is presently recruiting participants. This research endeavour was first unveiled on September 1st 2020 and has undergone a recent update as of April 27th 2022."

Answered by AI

How many participants are being recruited to take part in this experiment?

"Affirmative. Information from clinicaltrials.gov implies that this trial, which was first published on 1/9/2020 and most recently updated 4/27/2022, is actively recruiting participants. The research team are looking to enrol 140 people across a single location."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I am on a downward spiral and I am seeing less and less chances of hope in my existence.
PatientReceived 2+ prior treatments
~18 spots leftby Apr 2025